| Primary |
| Epilepsy |
29.9% |
| Product Used For Unknown Indication |
23.1% |
| Convulsion |
6.0% |
| Bipolar I Disorder |
5.2% |
| Bipolar Disorder |
4.5% |
| Prophylaxis Of Neural Tube Defect |
3.7% |
| Temporal Lobe Epilepsy |
3.7% |
| Depression |
3.0% |
| Mood Altered |
3.0% |
| Sedation |
3.0% |
| Affective Disorder |
2.2% |
| Bipolar Ii Disorder |
2.2% |
| Contraception |
1.5% |
| Glaucoma |
1.5% |
| Hypertension |
1.5% |
| Intentional Overdose |
1.5% |
| Mood Swings |
1.5% |
| Sedative Therapy |
1.5% |
| Dysthymic Disorder |
0.7% |
| Petit Mal Epilepsy |
0.7% |
|
| Haemorrhagic Disorder |
11.4% |
| Foetal Exposure During Pregnancy |
6.8% |
| Hip Dysplasia |
6.8% |
| Inappropriate Antidiuretic Hormone Secretion |
6.8% |
| Multi-organ Failure |
6.8% |
| Oxygen Saturation Decreased |
6.8% |
| Rash |
6.8% |
| Circulatory Collapse |
4.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.5% |
| Maternal Exposure During Pregnancy |
4.5% |
| Myelodysplastic Syndrome |
4.5% |
| Platelet Count Increased |
4.5% |
| Shock |
4.5% |
| Suicidal Ideation |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Abnormal Behaviour |
2.3% |
| Amnesia |
2.3% |
| Anaemia |
2.3% |
| Angioedema |
2.3% |
| Atrial Septal Defect |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
37.8% |
| Epilepsy |
24.8% |
| Convulsion |
7.1% |
| Affective Disorder |
5.9% |
| Bipolar I Disorder |
3.8% |
| Bipolar Disorder |
3.4% |
| Mental Disorder |
2.9% |
| Sedation |
2.5% |
| Major Depression |
1.7% |
| Glaucoma |
1.3% |
| Grand Mal Convulsion |
1.3% |
| Hypertension |
1.3% |
| Urinary Tract Infection |
1.3% |
| Adjustment Disorder With Depressed Mood |
0.8% |
| Complex Partial Seizures |
0.8% |
| Depression |
0.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
0.8% |
| Intentional Overdose |
0.8% |
| Anaemia |
0.4% |
| Atrial Fibrillation |
0.4% |
|
| Completed Suicide |
17.2% |
| Haemorrhagic Disorder |
14.1% |
| Cardiac Arrest |
6.3% |
| Convulsion |
6.3% |
| Maternal Exposure During Pregnancy |
6.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.7% |
| Inappropriate Antidiuretic Hormone Secretion |
4.7% |
| Parasomnia |
4.7% |
| Respiratory Arrest |
4.7% |
| Toxicity To Various Agents |
4.7% |
| Abnormal Behaviour |
3.1% |
| Bradycardia Neonatal |
3.1% |
| Exposure During Breast Feeding |
3.1% |
| Foetal Exposure During Pregnancy |
3.1% |
| Maternal Drugs Affecting Foetus |
3.1% |
| Neuroleptic Malignant Syndrome |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Bundle Branch Block Left |
1.6% |
| Cerebral Haemorrhage |
1.6% |
| Circulatory Collapse |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.5% |
| Epilepsy |
22.2% |
| Bipolar Disorder |
6.0% |
| Convulsion |
5.6% |
| Schizophrenia |
4.6% |
| Depression |
4.2% |
| Multiple Myeloma |
3.7% |
| Multiple Sclerosis |
3.7% |
| Rheumatoid Arthritis |
3.2% |
| Anxiety |
2.3% |
| Hypertension |
2.3% |
| Prophylaxis |
2.3% |
| Arthritis |
1.9% |
| Convulsion Prophylaxis |
1.9% |
| Hypothyroidism |
1.9% |
| Insomnia |
1.9% |
| Non-small Cell Lung Cancer Stage Iv |
1.9% |
| Schizoaffective Disorder |
1.9% |
| Tuberous Sclerosis |
1.9% |
| Affective Disorder |
1.4% |
|
| Convulsion |
10.9% |
| Logorrhoea |
10.9% |
| Fall |
6.5% |
| Pulmonary Embolism |
6.5% |
| Anxiety |
4.3% |
| Atrial Flutter |
4.3% |
| Brain Oedema |
4.3% |
| Cytolytic Hepatitis |
4.3% |
| Drug Effect Delayed |
4.3% |
| Gait Disturbance |
4.3% |
| Limb Operation |
4.3% |
| Nausea |
4.3% |
| Oesophageal Squamous Cell Carcinoma |
4.3% |
| Off Label Use |
4.3% |
| Orthostatic Hypotension |
4.3% |
| Rash |
4.3% |
| Ulcer |
4.3% |
| Vomiting |
4.3% |
| Aggression |
2.2% |
| Alopecia |
2.2% |
|
| Interacting |
| Back Pain |
66.7% |
| Product Used For Unknown Indication |
33.3% |
|
| White Blood Cell Count Decreased |
100.0% |
|
